Terms: = Gastric cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Clinical Outcome
3 results:
1. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial.
Van Cutsem E; de Haas S; Kang YK; Ohtsu A; Tebbutt NC; Ming Xu J; Peng Yong W; Langer B; Delmar P; Scherer SJ; Shah MA
J Clin Oncol; 2012 Jun; 30(17):2119-27. PubMed ID: 22565005
[TBL] [Abstract] [Full Text] [Related]
2. Nuclear translocation of pro-amphiregulin induces chemoresistance in gastric cancer.
Yoshida M; Shimura T; Fukuda S; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Nakazawa T; Higashiyama S; Joh T
Cancer Sci; 2012 Apr; 103(4):708-15. PubMed ID: 22320154
[TBL] [Abstract] [Full Text] [Related]
3. [Expression and significance of rhoa and NF-ΚB in human gastric carcinoma].
Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498
[TBL] [Abstract] [Full Text] [Related]